ºÐ´ç¼­¿ï´ë Á¤¼ºÁø ±³¼ö-º¹¾Ð¼º¿ä½Ç±Ý ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻çÀÇ Å¸´ç¼º¿¡ ´ëÇÑ °íÂû
2011/12/25 09:55 ÀÔ·Â
Æ®À§ÅÍ·Î ±â»çÀü¼Û ÆäÀ̽ººÏÀ¸·Î ±â»çÀü¼Û
¡ã ºÐ´ç¼­¿ï´ëÇб³º´¿ø ºñ´¢±â°ú Á¤¼ºÁø ±³¼ö

I. ¼­·Ð

ÇöÀç º¹¾Ð¼º¿ä½Ç±ÝÀÇ ¼ö¼úÀû Ä¡·á ¹æ¹ýÀ¸·Î ³Î¸® ½ÃÇàµÇ°í ÀÖ´Â Áߺο䵵½½¸µ (mid-urethral sling) ¼ö¼ú¹ýÀº 1992³â Ulmsten°ú Petros°¡ Á¦¾ÈÇÑ Áߺο䵵 ÀÌ·Ð (integral theory)¿¡ ¹ÙÅÁÀ» µÐ °ÍÀ¸·Î, Àΰø ¸Þ½¬¸¦ ÀÌ¿ëÇÏ¿© ¾àÈ­µÈ Ä¡°ñ-¿äµµ Àδë (pubo-urethral ligament)¸¦ °­È­½ÃÄÑÁÖ´Â ¹æ¹ýÀÌ´Ù [1]. ±¹³»¿¡´Â 1990³â´ë ÈĹݺÎÅÍ º¸±ÞµÇ¾î, ÇöÀç ´ë´Ù¼öÀÇ º¹¾Ð¼º¿ä½Ç±Ý ¼ö¼ú¹ýÀ¸·Î ÀÚ¸®Àâ¾Ò°í, Àü¼¼°èÀûÀ¸·Îµµ °¡Àå ¸¹ÀÌ ½ÃÇàµÇ´Â º¹¾Ð¼º¿ä½Ç±Ý ¼ö¼ú¹ýÀÌ´Ù [2]. °ú°Å ¼ö¼ú¹ý¿¡ ºñÇؼ­ ´ú ħ½ÀÀûÀ̸鼭µµ, ¼º°ø·üÀÌ ³ô°í, ÃÖ±Ù¿¡´Â 10³â ÀÌ»ó Àå±â°£ È¿°ú°¡ À¯ÁöµÇ´Â È¿°úÀûÀÎ ¼ö¼ú¹ýÀ¸·Î º¸°íµÇ°í ÀÖ´Ù [3]. ±×·¯³ª, ¼ö¼ú ¼º°ø·üÀÌ ³ô±â´Â Çϳª, ¿©·¯ ¿¬±¸µé¿¡¼­ Áߺο䵵½½¸µ ¼ö¼ú ¼º°ø·ü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ´Ù¾çÇÑ ÀÎÀÚµéÀÌ º¸°íµÇ¾ú´Âµ¥, ƯÈ÷, ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻翡¼­ ¹ß°ßµÇ´Â ¹è´¢±Ù°úÈ°µ¿ [4], ¹è´¢±Ù ¼öÃà·Â ÀúÇÏ [5,6], ±×¸®°í ±â´ÉÀå¾Ö¼º ¹è´¢ (dysfunctional voiding) [7]µîÀº Áß¿ä ¼ö¼ú ½ÇÆÐ ¿¹ÃøÀÎÀÚ·Î Àνĵǰí ÀÖ´Ù.
ÀϹÝÀûÀ¸·Î ¿ä¿ªµ¿Çа˻ç´Â ¹æ±¤°ú ¿äµµÀÇ ±â´ÉÀû ÀÌ»óÀ» È®ÀÎÇÏ´Â °¡Àå È®½ÇÇÏ°í °´°üÀûÀÎ ¹æ¹ýÀ¸·Î ÀÎÁ¤¹Þ°í ÀÖÀ¸¸ç, ÀÓ»óÁø·á¿¡¼­ ½Å°æÀμº¹æ±¤À̳ª, ¿øÀÎÀÌ ¾Ö¸ÅÇÑ ¹è´¢Áõ»ó µî ´Ù¾çÇÑ ¹è´¢ °ü·Ã ÀÌ»óÀÇ ¿øÀÎÀ» Áø´ÜÇÏ°í Ä¡·á¹ýÀ» Á¦½ÃÇϴµ¥ ¾ø¾î¼­´Â ¾ÈµÉ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ°í ÀÖ´Ù. ¿ä½Ç±Ý ȯÀÚÀÇ Æò°¡¿¡ À־´Â, ÀÓ»óÁõ»ó¿¡¼­ ¹è´¢±Ù°úÈ°µ¿ÀÌ ÀǽɵǴ °æ¿ì, ÀÌÀü ¿ä½Ç±Ý ¼ö¼úÀÌ ½ÇÆÐÇÑ °æ¿ì, °ñ¹ÝÀå±âÅ»ÃâÁõÀÌ µ¿¹ÝµÇ¾î ÀÖ´Â °æ¿ì, ´Ù¸¥ ¹è´¢Àå¾Ö¸¦ ½Ã»çÇÒ ¸¸ÇÑ Áõ»óÀÌ ÀÖ´Â °æ¿ì¿¡ ÁÖ·Î ½ÃÇàµÇ°í ÀÖ´Ù. ±×·¯³ª, ÃÖ±Ù ±¹³»ÀÇ ÀÏ°¢¿¡¼­ º¹¾Ð¼º¿ä½Ç±Ý ¼ö¼ú Àü¿¡ ¿ä¿ªµ¿Çа˻縦 ½ÃÇàÇÏ´Â °Í¿¡ ´ëÇÑ ºñÆÇÀûÀÎ ÀÇ°ßÀÌ Á¦½ÃµÇ¾ú°í, ¸î¸î ¾ð·Ð ¸Åü¿¡¼­ ÀÌ ¹®Á¦¿¡ ´ëÇؼ­ º¸µµÇϱ⵵ ÇÏ¿´´Ù. ÀúÀÚ´Â ÇöÀç±îÁö ¹ßÇ¥µÈ ¿©·¯ ¿¬±¸°á°ú¸¦ ¹ÙÅÁÀ¸·Î º¹¾Ð¼º¿ä½Ç±Ý ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻çÀÇ Å¸´ç¼º¿¡ ´ëÇؼ­ °íÂûÇÏ°íÀÚ ÇÑ´Ù.

II. º¹¾Ð¼º¿ä½Ç±Ý ¼ö¼ú ½ÇÆÐ ÀÎÀÚ

º¹¾Ð¼º¿ä½Ç±Ý ¼ö¼ú Àü ¿ä¿ªµ¿ÇÐ°Ë»ç ½Ç½ÃÀÇ ¸ñÀûÀº ¾Õ¼­ ¾ð±ÞÇÑ ¼ö¼ú ½ÇÆÐÀÇ À§ÇèÀÎÀÚ¸¦ ¹Ì¸® ÆľÇÇÏ¿© À̸¦ Ä¡·á¹æħ °áÁ¤¿¡ ÀÌ¿ëÇÏ´Â °Í¿¡ ÀÖ´Ù°í ÇÒ ¼ö ÀÖ´Ù. ±×·¯³ª, ±¹³»ÀÇ °æ¿ì´Â ±¹°¡º¸Çè ±ÔÁ¤°ú ¸Â¹°·Á¼­, º¹¾Ð¼º¿ä´©Ãâ¾Ð (abdominal leak point pressure) ÀÚü¸¦ ÃøÁ¤ÇÏ´Â °ÍÀÌ ´õ Áß¿äÇÏ°Ô »ý°¢ µÇ¾îÁö´Â, ´Ù¼Ò ÀÌ»óÇÑ ÄÁ¼ÁÆ®°¡ Çü¼ºµÇ¾ú´Ù. ¹°·Ð, º¹¾Ð¼º¿ä½Ç±ÝÀÇ µÎ °¡Áö º´Å»ý¸®ÀÎ ¿äµµ°ú¿îµ¿¼º°ú ³»Àμº°ý¾à±Ù±â´ÉºÎÀüÀ» ±¸ºÐÇϴµ¥ µµ¿òÀ» ÁÖ´Â º¹¾Ð¼º¿ä´©Ãâ¾ÐÀ̳ª ÃÖ´ë¿äµµÆó¼â¾Ð (maximum urethral closing pressure)Àº ¿ä¿ªµ¿Çа˻çÀÇ Áß¿ä ÃøÁ¤ÁöÇ¥ÀÇ ÇÑ °¡ÁöÀÓ¿¡´Â Ʋ¸²¾ø´Ù. ƯÈ÷, ÇöÀçÀÇ Áߺο䵵½½¸µ ¼ö¼ú¹ýÀÌ º¸ÆíÈ­µÇ±â Àü¿¡, ÁÖ·Î ½ÃÇàµÇ¾ú´ø Burch ¼ú½Ä°ú Ä¡°ñÁú½Ä½½¸µ (pubovaginal sling) ¼ö¼ú¿¡¼­´Â º¹¾Ð¼º¿ä½Ç±ÝÀÇ µÎ °¡Áö º´Å»ý¸®°¡ ¼ö¼ú¹ýÀÇ ¼±Åÿ¡ Áß¿äÇÏ¿´±â ¶§¹®¿¡ [8,9], ¼ö¼ú Àü¿¡ º¹¾Ð¼º¿ä´©Ãâ¾Ð ÃøÁ¤À» ÅëÇؼ­ ¾î¶°ÇÑ º´Å»ý¸®ÀÎÁö È®ÀÎÇÏ´Â °ÍÀÌ Áß¿äÇÑ °úÁ¤À̾ú´Ù. ±×·¯³ª, ÃÖ±Ù¿¡ ÁÖ·Î ½ÃÇàµÇ´Â Áߺο䵵½½¸µ ¼ö¼úÀº ÀÌ µÎ °¡Áö º´Å»ý¸® ¸ðµÎ¿¡¼­ ¿ì¼öÇÑ ¼º°ø·üÀ» ³ªÅ¸³»°í ÀÖ°í [10], ÃÖ´ë¿äµµÆó¼â¾Ð°ú º¹¾Ð¼º¿ä´©Ãâ¾Ð¿¡ µû¸¥ ¼ö¼ú ¼º°ø·üÀÇ Â÷ÀÌ°¡ ¾ø´Ù´Â º¸°í°¡ ¸¹´Ù [11]. Áï, °ú°Å¿¡´Â ¼ö¼ú¹ýÀÇ ¼±Åÿ¡ ÃÖ´ë¿äµµÆó¼â¾Ð°ú º¹¾Ð¼º¿ä´©Ãâ¾ÐÀÌ Áß¿äÇÏ¿©, ÀÌ°ÍÀÌ ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻çÀÇ Áß¿ä ÃøÁ¤ÁöÇ¥¿´´Ù¸é, ÇöÀçÀÇ Áߺο䵵½½¸µ ½Ã´ë¿¡¼­´Â ÀÌ ÃøÁ¤ÁöÇ¥°¡ ¼ö¼ú ¼º°ø·ü ¿¹Ãø¿¡ ±×´ÙÁö Áß¿äÇÏÁö ¾ÊÀº °ÍÀÌ´Ù. ´ë½Å, ¾Õ¼­ ¾ð±ÞÇÑ, °ú°ÅºÎÅÍ º¹¾Ð¼º¿ä½Ç±Ý ¼ö¼ú ¼º°ø·ü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÀÎÀÚ·Î ¾Ë·ÁÁø ¹è´¢±Ù°úÈ°µ¿ [4], ¹è´¢±Ù ¼öÃà·Â ÀúÇÏ [5,6], ±×¸®°í ±â´ÉÀå¾Ö¼º ¹è´¢ [7]µîÀÌ ÇöÀçÀÇ Áߺο䵵½½¸µ ¼ö¼ú ½Ã´ë¿¡¼­µµ Áß¿ä ¼ö¼ú ½ÇÆÐ ¿¹ÃøÀÎÀÚ·Î ÀÎÁ¤µÇ°í ÀÖ´Ù. µû¶ó¼­ ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻翡¼­ ÃÖ´ë¿äµµÆó¼â¾Ð°ú º¹¾Ð¼º¿ä´©Ãâ¾ÐÀÇ ÃøÁ¤º¸´Ù, ¾Õ¼­ ¾ð±ÞÇÑ ¹æ±¤°ú ¿äµµÀÇ ±â´ÉÀû ÀÌ»óÀÌ ÀÖ´ÂÁö È®ÀÎÇÏ´Â °ÍÀÌ Áß¿äÇÏ´Ù°í ÇÒ ¼ö ÀÖ´Ù. ÇöÀçÀÇ º¹¾Ð¼º¿ä½Ç±Ý ¼ö¼úÀû Ä¡·á¿¡ ´ëÇÑ ´ëºÎºÐÀÇ °¡À̵å¶óÀε鿡¼­´Â ¾Õ¼­ ¾ð±ÞÇÑ ¼ö¼ú ½ÇÆÐ ¿¹ÃøÀÎÀÚ°¡ ÀÖÀ» °¡´É¼ºÀÌ Àִ ȯÀÚµé°ú, ´õºÒ¾î ÀÌÀü ¿ä½Ç±Ý ¼ö¼ú¿¡ ½ÇÆÐÇÑ °æ¿ì¿Í µ¿¹ÝµÈ °ñ¹ÝÀå±âÅ»ÃâÁõÀÌ ÀÖ´Â °æ¿ì¿¡´Â ¿¹¿Ü ¾øÀÌ ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻縦 ¹Ýµå½Ã ½ÃÇàÇÒ °ÍÀ» ¸í½ÃÇÏ°í ÀÖ´Ù [12-18].

III. ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻çÀÇ Çʿ伺¿¡ ´ëÇÑ ¼¼°è °¢ ±¹ÀÇ °¡À̵å¶óÀÎ

ÇöÀç±îÁö º¹¾Ð¼º¿ä½Ç±Ý ¼ö¼ú Àü ½ÃÇàÇÏ´Â ¿ä¿ªµ¿Çа˻çÀÇ °¡Ä¡¸¦ Æò°¡ÇÑ ´ë±Ô¸ð ÀüÇâÀû ¹«ÀÛÀ§ ¹èÁ¤ ¿¬±¸´Â ¾ø´Ù. ±×·¯³ª, Çö ½ÃÁ¡¿¡¼­ ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻çÀÇ °¡Ä¡¸¦ Æò°¡ÇÏÀÚ¸é, ÀÌ¿Í °ü·ÃµÈ ¿©·¯ °ü·Ã ÇÐȸµéÀÇ °¡À̵å¶óÀÎÀ» ÂüÁ¶ÇÏ´Â °ÍÀÌ Çö½ÇÀûÀÏ °ÍÀÌ´Ù. ºñ·Ï, ÀÌ·¯ÇÑ °¡À̵å¶óÀεé [12-18]ÀÌ ÁַΠȯÀÚ´ëÁ¶±º ¿¬±¸ ¹× ¼Ò±Ô¸ð ÀüÇâÀû ¿¬±¸¸¦ ¹ÙÅÁÀ¸·Î ÇÑ Áõ°Åµé°ú À̸¦ ¹ÙÅÁÀ¸·Î ÇÏ¿© °ü·Ã Àü¹®°¡ ÀÇ°ßÀ¸·Î ¸¸µé¾îÁ®¼­, Áõ°Å ¼öÁØÀÌ ³·Àº ÆíÀ̳ª, ÀÌ ºÐ¾ßÀÇ Àü¹®°¡µéÀÌ °ü·Ã ¿¬±¸ÀڷḦ ¹ÙÅÁÀ¸·Î, ¼­·Î ÇÕÀÇ¿¡ ÀÇÇØ ¿Ï¼ºÇÑ ÀÓ»óÁø·áÁöħÀ̱⠶§¹®¿¡, ´ë±Ô¸ð ÀüÇâÀû ¹«ÀÛÀ§ ¹èÁ¤ ¿¬±¸°¡ ¾ø´Â Çö ½ÃÁ¡¿¡¼­´Â, ÃæºÐÈ÷ Áø·áÀÇ Ç¥ÁØÁöħÀ¸·Î »ïÀ» ¸¸ÇÏ´Ù. ¼¼°è °¢ ±¹ÀÇ °ü·Ã ÇÐȸ °¡À̵å¶óÀε鿡¼­´Â º¹¾Ð¼º¿ä½Ç±Ý ¼ö¼ú Àü¿¡ ¹Ýµå½Ã ¿ä¿ªµ¿Çа˻縦 ½ÃÇàÇØ¾ß ÇÑ´Ù°í ¸í½ÃÇÏ°í ÀÖ´Ù [12-16]. ´ÙÀ½Àº ¼¼°è °¢±¹ÀÇ °¡À̵å¶óÀο¡¼­ ¸í½ÃÇÑ <º¹¾Ð¼º¿ä½Ç±Ý ¼ö¼ú Àü ¿ä¿ªµ¿ÇÐ°Ë»ç ½Ç½Ã>ÀÇ ÀÔÀåÀ» Á¤¸®ÇÏ¿´´Ù.

À¯·´ºñ´¢±â°úÇÐȸ (European Association of Urology) 2010³â [12]
<ÀÓ»óÀûÀ¸·Î Áø´ÜµÈ ¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý Áõ»ó>ÀÇ Ä¡·á·Î¼­ °¡¿ªÀûÀÎ Ä¡·á¹æ¹ý (Çൿġ·á, °ñ¹Ý±ÙÀ°¿îµ¿ µî)À» ½ÃµµÇÒ °æ¿ì´Â, ¿ä¿ªµ¿ÇÐ°Ë»ç ¾øÀÌ ÀÏÂ÷ÀûÀÎ ÀÓ»óÆò°¡ ÈÄ Ä¡·á ½ÃÀÛÀÌ °¡´ÉÇÏ´Ù (28 ÆäÀÌÁö - 5.1 Initial assessment & 5.2 Initial treatment of UI in women).
°¡¿ªÀûÀÎ ÀÏÂ÷Ä¡·á¿¡ È¿°ú°¡ ¾ø´Â °æ¿ì, ÁßÀçÀû Ä¡·á (interventional therapy)°¡ µµ¿òÀÌ µÉ ¼ö ÀÖ´Ù. ¿ä¿ªµ¿Çа˻ç´Â °Ë»ç °á°ú°¡ ÁßÀçÀû Ä¡·áÀÇ ¼±Åÿ¡ ¿µÇâÀ» ÁÙ °æ¿ì, ÀÌ·¯ÇÑ Ä¡·á Àü¿¡ ¿ä½Ç±ÝÀÇ ÇüŸ¦ Áø´ÜÇϱâ À§ÇØ °­·ÂÈ÷ ÃßõµÈ´Ù (31 ÆäÀÌÁö - 5.3.1 Assessment of specialized management of UI in women).
¿ä¿ªµ¿Çа˻ç·Î º¹¾Ð¼º¿ä½Ç±ÝÀÌ È®ÀεǾú´Ù¸é, ¿äµµ°ú¿îµ¿¼ºÀ» °¡Áø ȯÀÚ¿¡°Ô ÃÑüÀûÀÎ ºñ¼ö¼úÀû Ä¡·á, ÈÄÄ¡°ñ°ßÀÎ ¼ö¼ú, ¹æ±¤¸ñ/¿äµµ½½¸µ ¼ö¼ú µîÀÌ ÃßõµÉ ¼ö ÀÖ´Ù (31 ÆäÀÌÁö - 5.3.2 Treatment of specialized management of UI in women).
¿µ±¹ ¿Õ¸³ »êºÎÀΰú Çùȸ (Royal College of Obstetricians and Gynaecologists) 2003³â [13]
Áø¼º º¹¾Ð¼º¿ä½Ç±ÝÀ¸·Î ¼ö¼úÀ» ½ÃÇà ¹ÞÀ» ¿©¼ºµé¿¡¼­ Ä¡·á Àü¿¡ ¿ä¿ªµ¿Çа˻縦 ½ÃÇàÇؾ߸¸ ÇÏ´Â °ÍÀº ÃßõµÈ´Ù. ¼ö¼ú Àü ¿ä¿ªµ¿ÇÐ°Ë»ç ½Ç½Ã¿¡ ´ëÇÑ ÀÚ·á´Â ºÎÁ·ÇÏÁö¸¸, ºñ°¡¿ªÀûÀÎ ¼ö¼úÀ» ½ÃÇà ¹Þ±â Àü¿¡´Â, ¹è´¢°ï¶õÀ̳ª ¹è´¢±Ù°úÈ°µ¿ °°Àº ¼ö¼ú ½ÇÆÐ ¿¹ÃøÀÎÀÚ°¡ Á¸ÀçÇÑ´ÂÁö¿Í ¿ä½Ç±ÝÀÇ ÇüŸ¦ °´°üÀûÀ¸·Î Æò°¡ÇÏ´Â °ÍÀÌ À̵æÀÌ´Ù (7 ÆäÀÌÁö - 4. Preoperative management).

±¹Á¦ ºñ´¢ºÎÀΰúÇÐȸ (International Urogynecological Association) 2008³â [14]
ħ½ÀÀûÀÎ ¿ä¿ªµ¿Çа˻ç (Åë»óÀÇ ¿ä¿ªµ¿Çа˻ç)´Â ħ½ÀÀû ¶Ç´Â ¼ö¼úÀû Ä¡·á¸¦ °í·ÁÇϰųª, ÀÌÀüÀÇ ¼ö¼úÀû ¶Ç´Â º¸Á¸Àû Ä¡·á°¡ ½ÇÆÐÇϰųª, ¹è´¢Àå¾Ö, ½Å°æÀμº¹æ±¤, ¶Ç´Â ¼³¸íµÇÁö ¾Ê´Â ¿ä½Ç±ÝÀÌ ÀÖ´Â ¿©¼ºµé¿¡°Ô ±ÇÀåµÈ´Ù (21 ÆäÀÌÁö - Outcomes and UD testing; 22 ÆäÀÌÁö - Conclusions and recommendations).
Á¦ 4Â÷ ±¹Á¦ ¿ä½Ç±Ý ÇùÀÇȸ ±Ç°í (Fourth International Consultation on Incontinence Recommendations) 2010³â [15]
¿ä¿ªµ¿ÇÐ°Ë»ç °á°ú¿¡ µû¶ó Ä¡·á°¡ ¹Ù²ð °¡´É¼ºÀÌ Á¸ÀçÇÒ ¶§, Áï ¿ä½Ç±Ý°ú °ñ¹ÝÀå±âÅ»ÃâÁõ¿¡ ´ëÇÑ ´ëºÎºÐÀÇ Ä§½ÀÀûÀÎ Ä¡·á Àü¿¡´Â ¿ä¿ªµ¿ÇÐ°Ë»ç ½ÃÇàÀÌ ÃßõµÈ´Ù (216 ÆäÀÌÁö - Urodynamic testing).
°¡¿ªÀûÀÎ ÀÏÂ÷Ä¡·á¿¡ È¿°ú°¡ ¾ø´Â °æ¿ì, ÁßÀçÀû Ä¡·á (interventional therapy)°¡ ¿ä±¸µÉ ¼ö ÀÖ´Ù. ¿ä¿ªµ¿Çа˻ç´Â °Ë»ç °á°ú°¡ ÁßÀçÀû Ä¡·áÀÇ ¼±Åÿ¡ ¿µÇâÀ» ÁÙ °æ¿ì, ÀÌ·¯ÇÑ Ä¡·á Àü¿¡ ¿ä½Ç±ÝÀÇ ÇüŸ¦ Áø´ÜÇϰųª, Ä¡·á °èȹ¿¡ µµ¿òÀ» ¾ò±â À§ÇØ °­·ÂÈ÷ ÃßõµÈ´Ù (223 ÆäÀÌÁö -Specialized management).
±¹Á¦¿ä½Ç±ÝÇÐȸ ¿ä½Ç±Ý Á¦ 4ÆÇ (Incontinence 4th edition) 2009³â [16]
º¹¾Ð¼º¿ä½Ç±ÝÀ¸·Î ¼ö¼úÀû Ä¡·á¸¦ ¹ÞÀ» ¸ðµç ¿©¼ºµé¿¡°Ô ¼ö¼ú Àü¿¡ ¿ä¿ªµ¿Çа˻縦 ½ÃÇàÇØ¾ß ÇÑ´Ù (446 ÆäÀÌÁö - c) Aspects of urodynamic studies relevant to therapy for stress urinary incontinence).
¼ö¼úÀû Ä¡·á°¡ ¿¹Á¤µÇ¾î Àְųª, ¿ä½Ç±ÝÀÇ º´Å»ý¸®¿¡ Àǹ®ÀÌ Àְųª, ´Ü¼øÇÑ ¿ä½Ç±ÝÀÎÁö Àǽɽº·¯¿î °æ¿ì¿¡´Â, ÇÕ¸®ÀûÀÎ Ä¡·á¹æ¹ý °áÁ¤°ú Ä¡·á ¿¹ÈÄ¿¡ ´ëÇÑ Á¤º¸¸¦ ¾ò±â À§ÇØ ¸ðµç °æ¿ì¿¡¼­ ħ½ÀÀûÀÎ ¿ä¿ªµ¿Çа˻簡 ½ÃÇàµÇ¾îÁ®¾ß ÇÑ´Ù. ÀÌ°ÍÀº ´ÜÁö ¿ä½Ç±Ý ÀÚü¸¦ °Ë»çÇѴٱ⠺¸´Ù´Â ¹æ±¤°ú ¿äµµÀÇ ÀúÀå ¹× ¹è´¢ ±â´É¿¡ ´ëÇÑ ÃÑüÀûÀÎ °Ë»ç¸¦ ÀǹÌÇÑ´Ù (449 ÆäÀÌÁö - Recommendations for urodynamic studies in women with urinary incontinence).

µû¶ó¼­, ´ëºÎºÐÀÇ °¡À̵å¶óÀε鿡¼­, º¹¾Ð¼º¿ä½Ç±Ý ¼ö¼úÀ» ¿¹Á¤ÇÑ °æ¿ì´Â ¿¹¿Ü ¾øÀÌ ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻縦 ½Ç½ÃÇÒ °ÍÀ» ¸í½ÃÇÏ°í ÀÖ´Ù.

IV. <¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý Áõ»ó>¿¡¼­µµ ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻簡 ÇÊ¿äÇÑ°¡?

ÇöÀç ÀÏ°¢¿¡¼­ Á¦±âµÈ ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻çÀÇ °¡Ä¡¿¡ ´ëÇÑ Àǹ®ÀÇ Áß½ÉÀº <ÀÓ»óÀûÀ¸·Î Áø´ÜµÈ ¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý Áõ»ó>À» °¡Áö´Â ȯÀڵ鿡°Ô ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻縦 ½Ç½ÃÇÒ ÇÊ¿ä°¡ ¾ø´Ù´Â °ÍÀÏ °ÍÀÌ´Ù. ±×·¯³ª, ¾Õ¼­ »ìÆì º¸¾ÒµíÀÌ, ´ëºÎºÐÀÇ °¡À̵å¶óÀεéÀº ÀÓ»óÁõ»ó¿¡ »ó°ü¾øÀÌ <ºñ°¡¿ªÀûÀΠħ½ÀÀû ¼ö¼ú>À» ¾Õ µÐ °æ¿ì¿¡´Â ¹Ýµå½Ã ¿ä¿ªµ¿Çа˻縦 ½ÃÇàÇØ¾ß ÇÑ´Ù°í ¸í½ÃÇÏ°í ÀÖ´Ù. ´Ù¸¸, ÃÖ±Ù¿¡ National Institute for Health and Clinical Excellence (NICE) [17] °¡À̵å¶óÀο¡¼­ <ÀÓ»óÀûÀ¸·Î Áø´ÜµÈ ¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý Áõ»óÀ» °¡Áö´Â ȯÀڵ鿡¼­´Â ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻縦 ¹Ýµå½Ã ½Ç½ÃÇÒ ÇÊ¿ä´Â ¾ø´Ù>°í Á¦½ÃÇÏ¿´°í, ¶ÇÇÑ, ¹Ì±¹ºñ´¢±âÇÐȸ °¡À̵å¶óÀÎ [18]¿¡¼­ º¹¾Ð¼º¿ä½Ç±Ý ¼ö¼úÀ» ¾ÕµÐ, ´Ù¸¥ Áõ»óÀÌ ¾ø´Â °Ç°­ÇÑ ¿©¼º ȯÀڵ鿡 À־´Â, ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻縦 Ç¥ÁØ Æò°¡°¡ ¾Æ´Ñ, ±ÇÀå Æò°¡·Î ¹èÁ¤ÇÏ¿©, ³í¶õÀÌ µÇ¾ú´Ù.

<ÀÓ»óÀûÀ¸·Î Áø´ÜµÈ ¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý Áõ»ó>À» °¡Áö´Â ȯÀڵ鿡¼­ ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻縦 ½Ç½ÃÇÒ ÇÊ¿ä°¡ ¾ø´Ù´Â ÁÖÀåÀÌ ¼³µæ·ÂÀ» °¡Áö´Â À§Çؼ­´Â, ÀÌ·¯ÇÑ È¯ÀÚ ±ºÀ» ´ë»óÀ¸·Î, ¿ä¿ªµ¿Çа˻縦 ½Ç½ÃÇÏ¿© °ú¿¬ ¸î ÆÛ¼¾Æ®¿¡¼­ ¼ø¼ö º¹¾Ð¼º¿ä½Ç±ÝÀÌ ¾Æ´Ñ, ´Ù¸¥ ¹æ±¤°ú ¿äµµÀÇ ±â´ÉÀû ÀÌ»óÀÌ Á¸ÀçÇÏ´ÂÁö È®ÀÎÇÏ´Â °ÍÀÌ Áß¿äÇÒ °ÍÀÌ´Ù. ÀÌ¿¡ °üÇؼ­ ¸î¸î ¿¬±¸°¡ ¹ßÇ¥µÇ¾ú´Âµ¥, ÀÌ·¯ÇÑ È¯ÀÚ ±º¿¡¼­µµ 21.8-25.7%´Â ¼ø¼ö º¹¾Ð¼º¿ä½Ç±ÝÀÌ ¾Æ´Ñ, ´Ù¸¥ ±â´ÉÀû ÀÌ»óÀÌ µ¿¹Ý ¶Ç´Â ´Üµ¶À¸·Î Á¸ÀçÇÔÀÌ º¸°íµÇ¾ú´Ù [19,20]. ±¹³»ÀÇ °æ¿ìµµ ºñ½ÁÇÑ È¯ÀÚ ±ºÀÇ 20.9%¿¡¼­ ¼ö¼ú ½ÇÆп¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ´Â ¹è´¢±Ù°úÈ°µ¿, ¹è´¢±Ù ¼öÃà·Â ÀúÇÏ, ¶Ç´Â ¹æ±¤ÃⱸÆó»öÀÌ Á¸ÀçÇÑ´Ù°í º¸°íµÇ¾ú´Ù [21]. Áï, ´Ù¾çÇÑ ¿ä½Ç±Ý Áõ»óÀ» È£¼ÒÇÏ´Â Àüü ¿©¼ºµé¿¡¼­, <ÀÓ»óÀûÀ¸·Î ¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý Áõ»ó>À» °¡Áö´Â ¿©¼ºµé¸¸ ¼±º°ÇÑ´Ù°í Çصµ, 1/4 ¶Ç´Â 1/5¿¡¼­ ¼ö¼ú ¼º°ø·ü¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ´Â ´Ù¸¥ ¹æ±¤°ú ¿äµµÀÇ ±â´ÉÀû ÀÌ»óÀÌ ¹ß°ßµÈ´Ù´Â °ÍÀÌ´Ù. ¹®Á¦´Â À̸¦ ÀÓ»óÀûÀ¸·Î ¾î¶»°Ô ¹Ù¶óº¼ °ÍÀΰ¡? ÇÏ´Â °ÍÀÌ´Ù. ÇöÀçÀÇ Áߺο䵵½½¸µ ¼ö¼ú¹ýÀÌ °ú°Å ¼ö¼ú¹ý¿¡ ºñÇؼ­ ¾Æ¹«¸® ħ½Àµµ°¡ ³·¾ÆÁ³´Ù°í ÇÏ´õ¶óµµ, ¾ö¿¬È÷ <ºñ°¡¿ªÀûÀÎ ¼ö¼ú>ÀÌ°í, ¾Æ¹«¸® ÀÓ»óÁõ»óÀ¸·Î <¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý Áõ»ó>À» ¼±º°Çصµ, 1/4 ¶Ç´Â 1/5¿¡¼­´Â ¼ö¼ú ½ÇÆÐÀÇ À§ÇèÀÎÀÚÀÎ ¹æ±¤°ú ¿äµµÀÇ ±â´ÉÀû ÀÌ»óÀÌ Á¸ÀçÇÏ´Â °ÍÀÌ´Ù. ÀϹÝÀûÀ¸·Î °Ë»çÀÇ ¾ç¼º¿¹Ãøµµ´Â ±× Áý´Ü¿¡¼­ÀÇ Áúº´ À¯º´À²¿¡ ¿µÇâÀ» ¹ÞÁö¸¸, <ÀÓ»óÀûÀ¸·Î Áø´ÜµÈ ¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý Áõ»ó>ÀÌ ½ÇÁ¦ ¿ä¿ªµ¿Çа˻翡¼­ <¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý>À» ¿¹ÃøÇÏ´Â ¾ç¼º¿¹Ãøµµ°¡ ¿Ü±¹ÀÇ ¿¬±¸¿¡¼­ 74-78% [19,20]ÀÌ°í, ±¹³»ÀÇ ¿¬±¸¿¡¼­ 79.1% [21] ¼öÁØÀÓÀ» °¨¾ÈÇϸé, ºñ°¡¿ªÀûÀÎ ¼ö¼úÀ» ¾ÕµÐ <¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý Áõ»ó>À» °¡Áø ȯÀڵ鿡°Ô ¿ä¿ªµ¿Çа˻縦 »ý·«ÇÏ´Â °ÍÀº ÀûÀýÇÏÁö ¾ÊÀº °ÍÀ¸·Î »ý°¢µÈ´Ù. Áï, ºÒÇÊ¿äÇÑ ¼ö¼úÀ» ½ÃÇàÇϰųª, ¼ö¼ú ¼º°ø·üÀÌ ³·¾ÆÁö°í ÇÕº´ÁõÀÌ Áõ°¡ÇÒ ¼ö Àֱ⠶§¹®ÀÌ´Ù. ½ÇÁ¦·Î Basu µî [22]Àº ¿µ±¹ÀÇ °ü·Ã Àü¹®ÀǵéÀ» ´ë»óÀ¸·Î NICE °¡À̵å¶óÀÎ [17] ³»¿ë¿¡ ´ëÇÏ¿© ¼³¹®Á¶»ç¸¦ ½Ç½ÃÇÏ¿´´Âµ¥, ÀÀ´äÀÚÀÇ ¾à ¹Ý¼ö¿¡¼­ ÀÌ °¡À̵å¶óÀο¡ µû¶ó¼­ ½ÇÁ¦ ÀÓ»óÁø·á¸¦ ¹Ù²ÙÁö´Â ¾Ê°Ú´Ù°í ÇÏ¿´À¸¸ç, ±× Å« ÀÌÀ¯ ÁßÀÇ Çϳª°¡ <ÀÓ»óÀû ¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý Áõ»ó> ȯÀÚ¿¡¼­ ¼ö¼ú Àü¿¡ ¿ä¿ªµ¿Çа˻簡 ÇÊ¿äÇÏÁö ¾Ê´Ù´Â °Í¿¡ ´ëÇÑ ¹Ý´ë¿´´Ù.

ÀÓ»óÁõ»ó¸¸À¸·Î <¿ä¿ªµ¿ÇÐÀû ¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý>À» ¿¹ÃøÇÏ´Â °ÍÀº, ¾Õ¼­ º¸¾ÒµíÀÌ ¿¹ÃøÀÇ Á¤È®µµ°¡ ³ôÁö ¾ÊÀ» »Ó¸¸ ¾Æ´Ï¶ó, ÀÓ»óÁõ»óÀ¸·Î Á¤ÀÇÇÑ <¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý Áõ»ó>À» °¡Áö´Â ȯÀÚµéÀÌ, ´Ù¾çÇÑ ¿ä½Ç±Ý Áõ¼¼¸¦ °¡Áö´Â Àüü ȯÀÚµé Áß¿¡¼­ Â÷ÁöÇÏ´Â ºñÀ²ÀÌ ³·´Ù´Â Á¡¿¡¼­µµ ¹®Á¦Á¡ÀÌ ÀÖ´Ù. 2008³â º¸°íµÈ Agur µî [19]ÀÇ ¿¬±¸¿¡¼­´Â, ¿ä½Ç±ÝÀ¸·Î º´¿øÀ» ¹æ¹®ÇÑ Àüü 6,276¸íÀÇ ¿©¼ºµé¿¡°Ô NICE °¡À̵å¶óÀÎ [17]¿¡¼­ Á¦½ÃÇÑ <ÀÓ»óÀû ¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý Áõ»ó>À» È®ÀÎÇØ º¸´Ï, ´ÜÁö 324¸í¸¸ÀÌ È®ÀεǾî, Àüü ȯÀÚµéÀÇ 5.2%¿¡ Áö³ªÁö ¾Ê¾Ò´Ù. Digesu µî [20]ÀÇ ¿¬±¸¿¡¼­µµ Àüü ¿ä½Ç±Ý ¿©¼ºµé Áß ´ÜÁö 17.3%¸¸ Â÷ÁöÇÏ¿´°í, ±¹³»ÀÇ ¿¬±¸ [21]¿¡¼­µµ Àüü ¿ä½Ç±Ý ¿©¼º 1,019¸í Áß¿¡¼­ ´ÜÁö 211¸í (20.7%)¸¸ÀÌ  <ÀÓ»óÀû ¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý Áõ»ó>À» º¸¿´´Ù. NICE °¡À̵å¶óÀÎ [17] Á¶Â÷µµ ÀÌ·¯ÇÑ È¯ÀÚ ±ºÀ» ¡°the small group of women with a clearly defined clinical diagnosis of pure SUI¡¦¡±·Î Ç¥ÇöÇÏ°í ÀÖ´Ù. µû¶ó¼­ ½ÇÁ¦ÀûÀ¸·Î, ÀÓ»óÁø·á¿¡¼­ ÀÌ·¯ÇÑ Áõ»ó ±ºÀ» °¡Áö´Â ȯÀÚ ±ºÀÇ ºñÀ²Àº ÀÛÀº °ÍÀÌ°í, ÀÌ °æ¿ì, ÀÓ»óÁõ»óÀ» ÀÌ¿ëÇÑ ¿ä¿ªµ¿ÇÐ°Ë»ç °á°ú ¿¹ÃøÀº, ÀÓ»óÀû À¯¿ë¼ºÀÌ Á¦ÇÑÀûÀÏ ¼ö ¹Û¿¡ ¾ø´Ù.

V. ÁøÇà ÁßÀÎ ¿¬±¸

ÇöÀç º¹¾Ð¼º¿ä½Ç±Ý¿¡¼­ ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻çÀÇ °¡Ä¡¸¦ Æò°¡ÇÑ ´ë±Ô¸ð ÀüÇâÀû ¹«ÀÛÀ§ ¹èÁ¤ ¿¬±¸´Â ¾ø´Â ½ÇÁ¤ÀÌ´Ù. ±×·¯³ª, ´ÙÇàÈ÷ ÀÌ¿¡ °üÇÑ µÎ °¡Áö ¿¬±¸°¡ ÇöÀç ÁøÇà Áß¿¡ Àִµ¥, Urinary Incontinence Treatment NetworkÀÇ ÁÖµµ·Î ÁøÇàµÇ°í ÀÖ´Â The Value of Urodynamic Evaluation trial [23]°ú Dutch consortium¿¡¼­ ÁøÇàÇÏ°í ÀÖ´Â The Value of Urodynamics Prior to Stress Incontinence Surgery study [24]°¡ ±×°ÍÀÌ´Ù. Çâ ÈÄ 2-3³â µÚ¿¡ ¿¬±¸°á°ú°¡ ¹ßÇ¥µÇ¸é, º¹¾Ð¼º¿ä½Ç±Ý ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻çÀÇ °¡Ä¡¿¡ ´ëÇÑ ¸¹Àº ±Ã±ÝÁõµéÀÌ ÇØ¼ÒµÉ ¼ö ÀÖÀ» °ÍÀ¸·Î »ý°¢ÇÑ´Ù. ±×·¯³ª, Çö ½ÃÁ¡¿¡¼­, ´õ ¸íÈ®ÇÑ Áõ°ÅµéÀÌ ³ª¿À±â Àü±îÁö´Â, °ü·Ã ºÐ¾ßÀÇ ¸¹Àº °¡À̵å¶óÀεé [12-16]¿¡¼­ Á¦½ÃÇÏ¿´µíÀÌ, ȯÀÚÀÇ Áõ»ó¿¡¼­ ¹æ±¤°ú ¿äµµÀÇ ±â´ÉÀû ÀÌ»óÀÌ ÀǽɵǴ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, <ÀÓ»óÀû ¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý Áõ»ó>¸¸ ÀÖ´õ¶óµµ, <ºñ°¡¿ªÀûÀÎ ¼ö¼úÀû Ä¡·á>¸¦ °èȹÇÑ´Ù¸é, ¹Ýµå½Ã ¿ä¿ªµ¿Çа˻縦 ½Ç½ÃÇÏ´Â °ÍÀÌ Å¸´çÇÏ´Ù°í ÇÒ ¼ö ÀÖ°Ú´Ù.

VI. °á·Ð

Áö±Ý±îÁö Á¦½ÃµÈ ¿¬±¸°á°ú¸¦ ¹ÙÅÁÀ¸·Î º¹¾Ð¼º¿ä½Ç±Ý ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻çÀÇ Å¸´ç¼º¿¡ ´ëÇؼ­ °íÂûÇغ¸¾Ò´Ù. Á¾ÇÕÇϸé, ÇöÀçÀÇ Áߺο䵵½½¸µ ¼ö¼ú ½Ã´ë¿¡¼­ ¼ö¼ú Àü ½ÃÇàµÇ´Â ¿ä¿ªµ¿Çа˻çÀÇ ÀÇÀÇ´Â º¹¾Ð¼º¿ä´©Ãâ¾ÐÀ̳ª ÃÖ´ë¿äµµÆó¼â¾Ð ÃøÁ¤À» ÅëÇÑ º¹¾Ð¼º¿ä½Ç±ÝÀÇ º´Å»ý¸®¸¦ Æò°¡ÇÏ´Â °Íº¸´Ù´Â, º¹¾Ð¼º¿ä½Ç±Ý ¿Ü¿¡ ¹æ±¤À̳ª ¿äµµÀÇ ´Ù¸¥ ±â´ÉÀû ÀÌ»óÀ» ¹Ì¸® ¹ß°ßÇÏ¿©, À̸¦ Ä¡·á¹æħ °áÁ¤¿¡ Àû¿ëÇÔÀ¸·Î½á, ¼ö¼úÀÇ ¼º°ø·üÀ» ³ôÀÌ°í, ºÒÇÊ¿äÇÑ ¼ö¼úÀ» ¹æÁöÇÏ´Â °ÍÀÌ´Ù. ÇöÀçÀÇ ¸ðµç °¡À̵å¶óÀεéÀº ÀÌ·¯ÇÑ ¼ö¼ú ½ÇÆÐ À§ÇèÀÎÀÚ°¡ ÀÖ´Â ¸ðµç ȯÀڵ鿡¼­ ¼ö¼ú Àü ¿ä¿ªµ¿Çа˻縦 ½Ç½ÃÇÒ °ÍÀ» ¸í½ÃÇÏ°í ÀÖ´Ù. ƯÈ÷, ¿ä¿ªµ¿Çа˻縦 ¹èÁ¦ÇÏ°í ȯÀÚÀÇ Áõ»óÀ» Æ÷ÇÔÇÑ ÀÓ»ó°Ë»ç¸¸À¸·Î ¿ä¿ªµ¿Çа˻çÀÇ <¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý>À» ¿¹ÃøÇÏ¿´À» ¶§, 1/4 ¶Ç´Â 1/5¿¡¼­, ¼ö¼ú ¼º°ø·ü¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ´Â ´Ù¸¥ ¹æ±¤°ú ¿äµµÀÇ ±â´ÉÀû ÀÌ»óÀÌ ¹ß°ßµÈ´Ù´Â Á¡Àº, ÇöÀç ³í¶õÀÌ µÇ°í ÀÖ´Â <ÀÓ»óÀû ¼ø¼ö º¹¾Ð¼º¿ä½Ç±Ý Áõ»ó> ȯÀڵ鿡°Ôµµ ¼ö¼ú Àü¿¡´Â ¹Ýµå½Ã ¿ä¿ªµ¿Çа˻縦 ½Ç½ÃÇØ¾ß ÇÏ´Â ±Ù°Å¸¦ Á¦½ÃÇÑ´Ù°í ÇÒ ¼ö ÀÖ´Ù.

[Âü°í¹®Çå]
1. Ulmsten U, Petros P. Surgery for female urinary incontinence. Curr Opin Obstet Gynecol 1992;4:456-62.
2. Shah AD, Kohli N, Rajan SS, et al. The age distribution, rates, and types of surgery for stress urinary incontinence in the USA. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:89-96.
3. Olsson I, Abrahamsson AK, Kroon UB. Long-term efficacy of the tension-free vaginal tape procedure for the treatment of urinary incontinence: A retrospective follow-up 11.5 years post-operatively. Int Urogynecol J Pelvic Floor Dysfunct 2010;21:679-83.
4. Kenton K, Richter H, Litman H, et al. Risk factors associated with urge incontinence after continence surgery. J Urol 2009;182:2805-9.
5. Kuo HC. Effect of detrusor function on the therapeutic outcome of a suburethral sling procedure using a polypropylene sling for stress urinary incontinence in women. Scand J Urol Nephrol 2007;41:138-43.
6. Gateau T, Faramarzi-Roques R, LeNormand L, et al. Clinical and urodynamic repercussions after TVT procedure and how to diminish patient complaints. Eur Urol 2003;44:372-6.
7. Wang AC, Chen MC. The correlation between preoperative voiding mechanism and surgical outcome of the tension-free vaginal tape procedure, with reference to quality of life. BJU Int 2003;91:502-6.
8. McGuire EJ, Fitzpatrick CC, Wan J, et al. Clinical assessment of urethral sphincter function. J Urol 1993;150:1452-4.
9. Haab F, Zimmern PE, Leach GE. Female stress urinary incontinence due to intrinsic sphincteric deficiency: recognition and management. J Urol 1996;156:3-17.
10. Bai SW, Jung YH, Jeon MJ, et al. Treatment outcome of tension-free vaginal tape in stress urinary incontinence: comparison of intrinsic sphincter deficiency and nonintrinsic sphincter deficiency patients. Int Urogynecol J Pelvic Floor Dysfunct 2007;18:1431-4.
11. Costantini E, Lazzeri M, Giannantoni A, et al. Preoperative MUCP and VLPP did not predict long-term (4-year) outcome after transobturator mid-urethral sling. Urol Int 2009;83:392-8.
12. Schr?der A, Abrams P, Andersson KE, et al. Guidelines on urinary incontinence. EAU Guideline 2010. Available at: http://www.uroweb.org/gls/pdf/Urinary Incontinence 2010.pdf. Accessed 13 June 2011.
13. Royal College of Obstericians and Gynaecologists (RCOG). Surgical treatment of urodynamic stress incontinence. RCOG Guideline 35 2003; 35. Available at: http://www.rcog.org.uk/files/rcog-corp/uploaded-files/GT35UrodynamicStressIncontinence2003.pdf. Accessed 13 June 2011.
14. Ghoniem G, Stanford E, Kenton K, et al. Evaluation and outcome measures in the treatment of female urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and clinical practice. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:5-33.
15. Abrams P, Andersson KE, Birder L, et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29:213-40.
16. Hosker G, Rosier P, Gajewski J, Sand P, Szabo L, Capewell A. Committee 6 Dynamic Testing. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence. 4th ed. Paris: Health Publication Ltd; 2009. p. 413-522
17. NICE. Urinary incontinence. The management of urinary incontinence in women. NICE Clinical Guideline 40 2006; 40. Available at: http://www.nice.org.uk/nicemedia/pdf/CG40NICEguideline.pdf. Accessed 13 June 2011.
18. Dmochowski RR, Blaivas JM, Gormley EA, et al. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol 2010;183:1906-14.
19. Agur W, Housami F, Drake M, et al. Could the National Institute for Health and Clinical Excellence guidelines on urodynamics in urinary incontinence put some women at risk of a bad outcome from stress incontinence surgery? BJU Int 2008;103:635-9.
20. Digesu GA, Hendricken C, Fernando R, et al. Do women with pure stress urinary incontinence need urodynamics? Urology 2009;74:278-81.
21. Jeong SJ, Chung MS, Nam JS, et al. Should urodynamic study be carried out in all women with clinically-defined pure stress urinary incontinence prior to surgical intervention? Paper presented at: 2010 Annual Meeting of Korean Urological Association November 17-19, 2010; Seoul, Korea.
22. Basu M, Duckett JR, Moran P, et al. Clinicians' views on the NICE guideline on the management of female urinary incontinence. J Obstet Gynaecol 2009;29:529-32.
23. Nager CW, Brubaker L, Daneshgari F, et al. Design of the Value of Urodynamic Evaluation (ValUE) trial: A non-inferiority randomized trial of preoperative urodynamic investigations. Contemp Clin Trials 2009;30:531-9.
24. van Leijsen SA, Kluivers KB, Mol BW, et al. Protocol for the value of urodynamics prior to stress incontinence surgery (VUSIS) study: a multicenter randomized controlled trial to assess the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered. BMC Womens Health 2009;9:22.

[ ÇÏÁ¤È¯ ±âÀÚ news@medicalilbo.com ]
ÇÏÁ¤È¯ ±âÀÚ ±âÀÚÀÇ ´Ù¸¥ ±â»ç º¸±â
±â»çÁ¦º¸ ¹× º¸µµÀÚ·á news@medicalilbo.com
¢Æ¢Æ ÀÇ·áÀϺ¸ ¢Æ¢Æ(www.medicalilbo.com) - copyright ¨Ï ¢Æ¢Æ ÀÇ·áÀϺ¸ ¢Æ¢Æ. ¹«´ÜÀüÀç & Àç¹èÆ÷ ±ÝÁö
´ñ±Û´Þ±â
  • ¸¹À̺»±â»ç
  • È­Á¦ÀÇ ´º½º

È­Á¦ÀÇ Æ÷Åä

È­Á¦ÀÇ Æ÷Åä´õº¸±â

    È­Á¦Àǵ¿¿µ»ó

    È­Á¦ÀÇ µ¿¿µ»ó
    • ȸ»ç¼Ò°³
    • ±¤°í¾È³»
    • Á¦ÈÞ·±¤°í¹®ÀÇ
    • ±â»çÁ¦º¸
    • Á¤±â±¸µ¶½Åû
    • °í°´¼¾ÅÍ
    • ÀúÀÛ±ÇÁ¤Ã¥
    • ȸ¿ø¾à°ü
    • °³ÀÎÁ¤º¸Ãë±Þ¹æħ
    • À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ
    • RSS
    • ÀÇ·áÀϺ¸ www.medicalilbo.com | ¼³¸³ÀÏ : 2009³â 9¿ù 7ÀÏ | ¥Ø 06653 ¼­¿ï½Ã ¼­Ãʱ¸ ¼­Ãʵ¿ 1589-14 ½Å¼º¿ÀÇǽºÅÚ Bµ¿ 407È£
      »ç¾÷ÀÚµî·Ï¹øÈ£ : 105-07-38362 | µî·Ï¹øÈ£ : ¼­¿ï½Ã ´Ù 09845
      ÀüÈ­ : 02) 333-3739, 363-3730 ±¤°í¹®ÀÇ : 02) 333-3739 | Æѽº 02) 363-3730 |  news@medicalilbo.com
      Copyright ¨Ï 2009 medicalilbo.com All right reserved.
      ¢Æ¢Æ ÀÇ·áÀϺ¸ ¢Æ¢ÆÀÇ ¸ðµç ÄÜÅÙÃ÷(±â»ç)´Â ÀúÀ۱ǹýÀÇ º¸È£¸¦ ¹Þ½À´Ï´Ù. ¹«´Ü ÀüÀç·º¹»ç·¹èÆ÷ µîÀ» ±ÝÇÕ´Ï´Ù.